TrialLeukemia & lymphoma2022

Continuous induction with lenalidomide/dexamethasone versus autologous stem cell transplantation in newly diagnosed multiple myeloma: a case for response-adapted approach.

Oscar B Lahoud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.